Genotoxicity evaluation of triptolide

TIAN Yijun; ZHENG Yiwen; ZHU Yuping; ZHANG Xiaofang; ZONG Ying; LU Guocai

doi:10.3969/j.issn.1006-0111.2016.03.006

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To study the genotoxicity of triptolide, an important active component of Tripterygium wilfordii Hook f. Methods Ames test, in vitro chromosomal aberration test of CHO cell and in vivo micronucleus assay were performed to investigate the genotoxicity of triptolide. Results The Ames test showed that triptolide did not increase mutagenicity for TA97, TA98, TA100, TA102 and TA1535 strains at the dosage of 1.6~1000 μg per plate with and without metabolic activation system S9. Results of in vitro CHO cell chromosomal aberration test indicated that there was no statistical difference between the triptolide groups (doses of 0.01, 0.02 and 0.04 μg/ml) and the solvent control group with and without metabolic activation system S9. However, triptolide significantly increased polychromatophilic erythrocyte micronucleus formation at the dosage of 720 μg/kg in ICR mice. Conclusion Triptolide did not induce genetic toxicity based on the Ames test and chromosomal aberration test, but could increase micronucleus formation at the dosage of 720 μg/kg. These results indicated that triptolide may have potential genotoxicity on human health.

Genotoxicity evaluation of triptolide

Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China

Received Date: 2015-11-15

Rev Recd Date: 2016-01-14

Key words:

Abstract: Objective To study the genotoxicity of triptolide, an important active component of Tripterygium wilfordii Hook f. Methods Ames test, in vitro chromosomal aberration test of CHO cell and in vivo micronucleus assay were performed to investigate the genotoxicity of triptolide. Results The Ames test showed that triptolide did not increase mutagenicity for TA97, TA98, TA100, TA102 and TA1535 strains at the dosage of 1.6~1000 μg per plate with and without metabolic activation system S9. Results of in vitro CHO cell chromosomal aberration test indicated that there was no statistical difference between the triptolide groups (doses of 0.01, 0.02 and 0.04 μg/ml) and the solvent control group with and without metabolic activation system S9. However, triptolide significantly increased polychromatophilic erythrocyte micronucleus formation at the dosage of 720 μg/kg in ICR mice. Conclusion Triptolide did not induce genetic toxicity based on the Ames test and chromosomal aberration test, but could increase micronucleus formation at the dosage of 720 μg/kg. These results indicated that triptolide may have potential genotoxicity on human health.

HTML

Reference (18)

[1]	张晓慧, 杨恩才, 万春平.雷公藤内酯醇及其衍生物的药理作用研究进展[J].云南中医中药杂志,2013,34(8):64-65.
[2]	国家食品药品监督管理总局.药物遗传毒性研究技术指导原则[EB/OL].2007-10-23[2015-11-15].http://www.sda.gov.cn/WS01/CL1616/90936.html.
[3]	周海钧.ICH药品注册的国际技术要求:安全性部分[M].北京:人民卫生出版社,2001:37-61.
[4]	OECD. Test Guidance 471:Bacterial Reverse Mutation Test[S]//OECD Guidance For Testing of Chemicals. Paris:Organization for Economic Cooperation & Development,1997:1-8.
[5]	OECD. Test Guidance 473:In Vitro Mammalian Chromosome Aberration Test[S]//OECD Guidance for Testing of Chemicals. Paris:Organization for Economic Cooperation & Development, 1997:1-7.
[6]	OECD. Test Guidance 474:Mammalian Erythrocyte Micronucleus Test[S]//OECD Guidance for Testing of Chemicals. Paris:Organization for Economic Cooperation & Development,1997:1-7.
[7]	张鹏宇, 张瑞,王雅贤.雷公藤内酯醇抗肿瘤分子机制研究进展[J].中医药学报,2009,37(3):79-82.
[8]	Ling D, Xia H, Park W, et al. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma[J]. ACS Nano, 2014, 8(8):8027-8039.
[9]	吴娜, 刘星雨,王笃军,等.雷公藤内酯醇对C57BL/6小鼠亚慢性毒性作用的研究[J]. 中成药, 2014,36(5):904-908.
[10]	周顺长, 吴越,王兵,等.雷公藤内酯醇聚合物胶束的急性毒性研究[J].医药导报, 2013, 32(12):1563-1565.
[11]	Qu L, Qu F, Jia Z, et al. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide[J]. J Ethnopharmacol, 2015, 170:28-38.
[12]	骆永伟, 施畅,原野,等.雷公藤甲素的毒理学研究进展[J]. 毒理学杂志, 2009,23(1):74-77.
[13]	Zhang J, Liu L, Mu X, et al. Effect of triptolide on estradiol release from cultured rat granulosa cells[J]. Endocr J, 2012, 59(6):473-481.
[14]	Jin J, Sun XZ, Zhao ZX, et al. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity[J]. Phytomedicine, 2015, 22(10):894-901.
[15]	高涛.雷公藤内酯醇靶蛋白及其药理机制研究进展[J].重庆医学,2012,41(35):3777-3780.
[16]	Ho LJ, Chang WL, Chen A, et al. Differential immunomodulatory effects by Tripterygium wilfordii Hook f-derived refined extract PG27 and its purified component PG490(triptolide) in human peripheral blood T cells:potential therapeutics for arthritis and possible mechanisms explaining in part Chinese herbal theory "Junn-Chenn-Zuou-SS"[J]. J Transl Med, 2013, 11:294.
[17]	Ma B, Qi HH, Li J, et al. Triptolide disrupts fatty acids and peroxisome proliferator-activated receptor (PPAR) levels in male mice testes followed by testicular injury:A GC-MS based metabolomics study[J]. Toxicology, 2015, 336:84-95.
[18]	杨建一, 高宝珍,李莉,等.雷公藤多甙对雄性小鼠生殖细胞毒性的研究[J].癌变·畸变·突变,2008,20(5):393-397.

Message Board

Genotoxicity evaluation of triptolide

doi: 10.3969/j.issn.1006-0111.2016.03.006

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views